Extracellular matrix associated protein CYR61 is linked to prostate cancer development
about
Sequencing and comparative genomic analysis of 1227 Felis catus cDNA sequences enriched for developmental, clinical and nutritional phenotypes.CCN1/CYR61: the very model of a modern matricellular protein.A novel anti-Cyr61 antibody inhibits breast cancer growth and metastasis in vivo.Cyr61/CCN1 is regulated by Wnt/β-catenin signaling and plays an important role in the progression of hepatocellular carcinomaCyr61 expression is associated with prognosis in patients with colorectal cancer.Decreased expression of Cyr61 is associated with prostate cancer recurrence after surgical treatment.CYR61 and TAZ Upregulation and Focal Epithelial to Mesenchymal Transition May Be Early Predictors of Barrett's Esophagus Malignant Progression.Aggressive rat prostate tumors reprogram the benign parts of the prostate and regional lymph nodes prior to metastasis.Cyr61/CTGF/Nov family proteins in gastric carcinogenesis.Cyr61 is a potential prognostic marker for prostate cancer.Krüppel-like factor 9 was down-regulated in esophageal squamous cell carcinoma and negatively regulated beta-catenin/TCF signaling.The matricellular protein CCN1 suppresses lung cancer cell growth by inducing senescence via the p53/p21 pathway.Cyr61 is regulated by cAMP-dependent protein kinase with serum levels correlating with prostate cancer aggressiveness.Serum Cyr61 as a potential biomarker for diagnosis of colorectal cancer.Knockdown of cysteine-rich 61 inhibits proliferation, migration, and invasiveness of prostate carcinoma PC-3 cells
P2860
Q30505291-17F253C8-9F19-4691-96EB-8FF1A998CE90Q34027926-B8E01BF4-7C1E-4E00-BB1C-358537FC9724Q34065731-3C0C7785-8FAE-4659-8DA2-5F590AF3CE2EQ34249375-A1454322-63BC-4649-BDFE-09CEC81E6E2BQ35113999-3F5C12E0-8440-40DE-882D-3A56EC3C1C46Q35176786-83666FAC-D2FD-4B7A-92BF-A9D9C7D6CE8DQ36119748-6EAD0AF7-B611-465E-B070-ECFB5E96D94FQ36363019-E58A6CDC-D821-404C-8737-D8CA6BEA4868Q37596182-80504CFB-E964-472D-BBEA-12BF05503FD4Q37985500-D658C4BB-BD35-4A03-B2F5-F085B1D29F76Q38914103-E4CA3160-C6CB-4611-8E95-7B6E6DB15911Q39171928-26C95839-C5A8-4664-A099-FE8B60CAC2B6Q39453245-114920A9-1D6C-48E1-8A6D-4B2404C7C032Q51392168-2C173C82-BABB-4EB4-8977-5E75658E76B7Q58139757-05B09975-673E-45B9-8682-2407AC5D76D5
P2860
Extracellular matrix associated protein CYR61 is linked to prostate cancer development
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Extracellular matrix associated protein CYR61 is linked to prostate cancer development
@ast
Extracellular matrix associated protein CYR61 is linked to prostate cancer development
@en
Extracellular matrix associated protein CYR61 is linked to prostate cancer development
@nl
type
label
Extracellular matrix associated protein CYR61 is linked to prostate cancer development
@ast
Extracellular matrix associated protein CYR61 is linked to prostate cancer development
@en
Extracellular matrix associated protein CYR61 is linked to prostate cancer development
@nl
prefLabel
Extracellular matrix associated protein CYR61 is linked to prostate cancer development
@ast
Extracellular matrix associated protein CYR61 is linked to prostate cancer development
@en
Extracellular matrix associated protein CYR61 is linked to prostate cancer development
@nl
P2093
P2860
P3181
P1476
Extracellular matrix associated protein CYR61 is linked to prostate cancer development
@en
P2093
Antoun Toubaji
Elizabeth A Platz
George J Netto
Katherine B D'Antonio
Robert H Getzenberg
Roula Albadine
P2860
P304
P3181
P356
10.1016/J.JURO.2009.12.006
P407
P577
2010-04-01T00:00:00Z